{"id":"W2911639050","doi":"10.1200/jco.2019.37.4_suppl.299","title":"Outcomes of patients with borderline-resectable pancreatic cancer treated with FOLFIRINOX versus gemcitabine plus nab-paclitaxel.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Saskatchewan Cancer Agency; University of Saskatchewan","funders":"","keywords":"FOLFIRINOX; Medicine; Gemcitabine; Oxaliplatin; Pancreatic cancer; Irinotecan; Internal medicine; Oncology; Population; Surgery; Cancer; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003248974,0.0001700298,0.0003384091,0.0002433217,0.0002747888,0.0004668512,0.0002555711,0.0003297573,0.000675878],"category_scores_gemma":[0.001025124,0.0001128001,0.0005581255,0.0003734108,0.0001920344,0.0003384768,0.0003123867,0.0003907735,0.0001399511],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001164105,"about_ca_system_score_gemma":0.0005658824,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003159755,"about_ca_topic_score_gemma":0.004731673,"domain_scores_codex":[0.9998561,0.00002939461,0.00001648518,0.00003449418,0.00002225888,0.00004129199],"domain_scores_gemma":[0.9994758,0.0000626442,0.0002378945,0.00001506544,0.00003146261,0.0001771262],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005578339,0.0002182909,0.9887396,0.00003218513,0.0001371647,0.0003140581,0.00006905971,0.0002889957,0.000496985,0.00001985124,0.0002123465,0.003892994],"study_design_scores_gemma":[0.000380761,0.004896272,0.9919081,0.00001960146,0.0001847879,0.001057055,0.0002383993,0.0005943064,0.0002392705,0.00004637643,0.0004249781,0.00001012344],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.999397,0.0002176267,0.00001605952,0.00003412686,0.000004307345,0.000009991313,0.0001523292,0.000001223402,0.0001674443],"genre_scores_gemma":[0.9994785,0.00007060506,0.0000172043,0.00002385494,0.000006517939,0.000007523834,0.0003524289,4.679107e-7,0.00004294265],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003159755,"threshold_uncertainty_score":0.008446217,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.083741180831066,"score_gpt":0.4561542741868971,"score_spread":0.3724130933558311,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}